Infectious Disease Diagnostic Testing Kit Market
Infectious Disease Diagnostic Testing Kit Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Infectious Disease Diagnostic Testing Kit Market Size and Growth
The Infectious Disease Diagnostic Testing Kit market is experiencing robust growth, driven by rising disease prevalence and technological advancements. The market is projected to reach approximately $7.2 billion by 2025, reflecting increasing demand for rapid and accurate testing solutions amid ongoing public health challenges and heightened focus on infectious disease management.
Companies Covered
(Covid 19 Impact Covered)
◍ Cellex
◍ Abbott
◍ Roche
◍ BioMedomics
◍ BD
◍ Henry Schein
◍ Safecare Bio-Tech
◍ Mayo Clinic Laboratories
◍ Chembio Diagnostics
◍ Mount Sinai Laboratory
◍ Ortho Clinical Diagnostics
◍ Zhejiang Orient Gene Biotech
◍ Innovita Biological Technology
◍ Guangzhou Wondfo Biotech
◍ Guangdong Hecin-Scientific
◍ Dynamiker Biotechnology (Tianjin)
◍ ADVAITE
The Infectious Disease Diagnostic Testing Kit Market features key players like Cellex, Abbott, and Roche, focusing on innovation and accessibility. Companies enhance market growth through diverse product offerings and strategic partnerships. Sales revenues include: Abbott: $42 billion (2022), Roche: $65 billion (2022), BD: $20 billion (2022).
Request Sample Report
Market Segmentation
By Application
Hospitals ◍ Scientific Research
By Product
◍ Bacteria Caused Disease ◍ Fungi Caused Disease
Parasites Caused Disease
Influenza
HIV
Ebola
COVID-19
Other Virus Caused Disease
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
